Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.83 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | SHBG | P04278 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15484202 | 1.00 | TSHR (0.83) | TSHRESR2CES2CES1EPHX2 | |
| SCHEMBL6911241 | 1.00 | TSHR (0.83) | TSHRESR2CES2CES1EPHX2 | |
| SCHEMBL9215694 | 0.96 | TSHR (0.91) | TSHRESR2CES2CES1EPHX2 | |
| SCHEMBL2197408 | 0.96 | TSHR (0.91) | TSHRESR2CES2CES1EPHX2 | |
| SCHEMBL11948880 | 0.96 | TSHR (0.91) | TSHRESR2CES2CES1EPHX2 | |
| SCHEMBL23121456 | 0.96 | TSHR (0.91) | TSHRESR2CES2CES1EPHX2 | |
| SCHEMBL811883 | 0.96 | TSHR (0.91) | TSHRESR2CES2CES1EPHX2 | |
| Cyclooctanol SCHEMBL40903 | 0.96 | — | — | |
| Cyclohexanol SCHEMBL5545 | 0.96 | — | — | |
| Cyclohexanol SCHEMBL8503956 | 0.96 | TSHR (0.91) | TSHRESR2CES2CES1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108774293-A | Compound, the manufacturing method of polymerizable compound and hydrazine compound | 日本瑞翁株式会社 | 2018-11-09 | — | — | CN | disclosed |
| CN-108780186-A | Optically anisotropic laminate, circularly polarizing plate, and image display device | 日本瑞翁株式会社 | 2018-11-09 | — | — | CN | disclosed |
| CN-105745233-B | Polymerizable compound, polymerizable composition, polymer, and optically anisotropic body | 日本瑞翁株式会社 | 2018-06-12 | — | — | CN | disclosed |
| EP-2700636-B1 | PROCESS FOR PREPARING EPISULFIDE COMPOUNDS | ASAHI CHEMICAL IND (JP) | 2017-08-02 | — | — | EP | disclosed |
| US-9359324-B2 | Process for preparing episulfide compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-06-07 | — | — | US | disclosed |
| US-20150197501-A1 | Process for Preparing Episulfide Compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-07-16 | — | — | US | disclosed |
| US-9051293-B2 | Process for preparing episulfide compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-06-09 | — | — | US | disclosed |
| US-20140107350-A1 | Process for Preparing Episulfide Compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-04-17 | — | — | US | disclosed |
| EP-2700636-A1 | PROCESS FOR PREPARING EPISULFIDE COMPOUNDS | Asahi Kasei Chemicals Corporation (JP) | 2014-02-26 | — | — | EP | disclosed |
| EP-0980028-B1 | Erasable image forming material | TOSHIBA KK (JP) | 2007-11-28 | — | — | EP | disclosed |
| US-6203603-B1 | COLOR FORMER, DEVELOPER, MATRIX AND POLYMER DECOLORIZER | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-03-20 | — | — | US | disclosed |
| EP-0980028-A1 | Erasable image forming material | KABUSHIKI KAISHA TOSHIBA (JP) | 2000-02-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150197501-A1 | Process for Preparing Episulfide Compounds | TST, EPHX2, STS | TSHR 1233/4885ESR2 129/4885CES2 495/4885 |
| US-20140107350-A1 | Process for Preparing Episulfide Compounds | TST, EPHX2, STS | TSHR 1233/4885ESR2 129/4885CES2 495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.